These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35211756)

  • 1. Significance of cancer stroma for bone destruction in oral squamous cell carcinoma using different cancer stroma subtypes.
    Shan Q; Takabatake K; Kawai H; Oo MW; Inada Y; Sukegawa S; Fushimi S; Nakano K; Nagatsuka H
    Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35211756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal cells in the tumor microenvironment promote the progression of oral squamous cell carcinoma.
    Shan Q; Takabatake K; Omori H; Kawai H; Oo MW; Nakano K; Ibaragi S; Sasaki A; Nagatsuka H
    Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34368860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between cancer and different cancer stroma subtypes promotes the infiltration of tumor‑associated macrophages into the tumor microenvironment of oral squamous cell carcinoma.
    Shan Q; Takabatake K; Kawai H; Oo MW; Sukegawa S; Fujii M; Nakano K; Nagatsuka H
    Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35514301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a xenograft model to explore the mechanism of bone destruction by human oral cancers and its application to analysis of role of RANKL.
    Tohyama R; Kayamori K; Sato K; Hamagaki M; Sakamoto K; Yasuda H; Yamaguchi A
    J Oral Pathol Med; 2016 May; 45(5):356-64. PubMed ID: 26859422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of bone invasion and underlying mechanisms of oral cancer using a cell line-derived xenograft model.
    Shan Q; Takabatake K; Omori H; Kawai H; Oo MW; Sukegawa S; Fujii M; Inada Y; Sano S; Nakano K; Nagatsuka H
    Oncol Lett; 2022 Nov; 24(5):382. PubMed ID: 36238359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-β synthesized by stromal cells and cancer cells participates in bone resorption induced by oral squamous cell carcinoma.
    Nakamura R; Kayamori K; Oue E; Sakamoto K; Harada K; Yamaguchi A
    Biochem Biophys Res Commun; 2015 Mar; 458(4):777-82. PubMed ID: 25681764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells.
    Sambandam Y; Ethiraj P; Hathaway-Schrader JD; Novince CM; Panneerselvam E; Sundaram K; Reddy SV
    J Cell Physiol; 2018 Aug; 233(8):6125-6134. PubMed ID: 29323724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
    Cui N; Nomura T; Noma H; Yokoo K; Takagi R; Hashimoto S; Okamoto M; Sato M; Yu G; Guo C; Shibahala T
    Clin Cancer Res; 2005 Apr; 11(7):2713-9. PubMed ID: 15814653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction.
    Oue E; Lee JW; Sakamoto K; Iimura T; Aoki K; Kayamori K; Michi Y; Yamashiro M; Harada K; Amagasa T; Yamaguchi A
    Biochem Biophys Res Commun; 2012 Aug; 424(3):456-61. PubMed ID: 22771802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells.
    Kayamori K; Sakamoto K; Nakashima T; Takayanagi H; Morita K; Omura K; Nguyen ST; Miki Y; Iimura T; Himeno A; Akashi T; Yamada-Okabe H; Ogata E; Yamaguchi A
    Am J Pathol; 2010 Feb; 176(2):968-80. PubMed ID: 20035059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer.
    Sato K; Lee JW; Sakamoto K; Iimura T; Kayamori K; Yasuda H; Shindoh M; Ito M; Omura K; Yamaguchi A
    Am J Pathol; 2013 May; 182(5):1890-9. PubMed ID: 23499553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma.
    Martin CK; Dirksen WP; Shu ST; Werbeck JL; Thudi NK; Yamaguchi M; Wolfe TD; Heller KN; Rosol TJ
    Oral Oncol; 2012 Jun; 48(6):491-9. PubMed ID: 22265717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of different osteoclast phenotypes in the progression of bone invasion by oral squamous cell carcinoma.
    Quan J; Hou Y; Long W; Ye S; Wang Z
    Oncol Rep; 2018 Mar; 39(3):1043-1051. PubMed ID: 29286135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
    Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
    Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness.
    Zhang JY; Zhu WW; Wang MY; Zhai RD; Wang Q; Shen WL; Liu LK
    J Transl Med; 2021 Dec; 19(1):513. PubMed ID: 34930321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THBS1 is induced by TGFB1 in the cancer stroma and promotes invasion of oral squamous cell carcinoma.
    Pal SK; Nguyen CT; Morita KI; Miki Y; Kayamori K; Yamaguchi A; Sakamoto K
    J Oral Pathol Med; 2016 Nov; 45(10):730-739. PubMed ID: 26850833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment.
    Sambandam Y; Sundaram K; Liu A; Kirkwood KL; Ries WL; Reddy SV
    Oncogene; 2013 Jan; 32(1):97-105. PubMed ID: 22330139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral squamous carcinoma cells secrete RANKL directly supporting osteolytic bone loss.
    Zhang X; Junior CR; Liu M; Li F; D'Silva NJ; Kirkwood KL
    Oral Oncol; 2013 Feb; 49(2):119-28. PubMed ID: 22989723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1 Generated by Oral Squamous Cell Carcinoma Stimulates Tumor-Induced and RANKL-Induced Osteoclastogenesis: A Possible Mechanism of Bone Resorption Induced by the Infiltration of Oral Squamous Cell Carcinoma.
    Fukawa Y; Kayamori K; Tsuchiya M; Ikeda T
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.